8-KThe WireRed Alert
Executive Change · Bylaw Amendment
Filed Nov 28, 2023 · 2y ago · Accession 0001193125-23-283693
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- 8-K
- Filing date
- Nov 28, 2023
- Report date
- Nov 22, 2023
- Document
- d610145d8k.htm
- Size
- 350 KB